Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Black Diamond Therapeutics Inc
(NQ:
BDTX
)
2.890
+0.150 (+5.47%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Black Diamond Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
November 01, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Black Diamond Therapeutics Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway
October 07, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Market Movers to Watch: Black Diamond (Nasdaq: BDTX), Peraso Inc. (NASDAQ: PRSO), Kaival Brands (NASDAQ: KAVL) among others w/Key Announcements
September 23, 2024
Via
AB Newswire
Looking Into Black Diamond Therapeutic's Recent Short Interest
August 22, 2024
Via
Benzinga
Black Diamond Therapeutic: Q4 Earnings Insights
March 12, 2024
Via
Benzinga
Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug
September 23, 2024
Black Diamond Therapeutics reports promising initial Phase 2 data for BDTX-1535 in relapsed EGFR-mutant NSCLC patients. With a 36% objective response rate and encouraging durability, BDTX-1535 shows...
Via
Benzinga
Black Diamond Therapeutics Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC who Present with a Broad Spectrum of Classical, Non-classical, and C797S Resistance Mutations
September 23, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Black Diamond Therapeutics to Host Webcast Presentation of Initial Phase 2 BDTX-1535 Data in Patients With Recurrent EGFRm NSCLC
September 22, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology (ESMO) Congress 2024
September 14, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors
August 08, 2024
From
Gyre Therapeutics, Inc.
Via
GlobeNewswire
BDTX Stock Earnings: Black Diamond Therapeutic Beats EPS for Q2 2024
August 06, 2024
BDTX stock results show that Black Diamond Therapeutic beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 06, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 11, 2024
Via
Benzinga
Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
June 01, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
May 29, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
BDTX Stock Earnings: Black Diamond Therapeutic Beats EPS for Q1 2024
May 09, 2024
BDTX stock results show that Black Diamond Therapeutic beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 09, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 23, 2024
Via
Benzinga
Black Diamond Therapeutics Announces Changes to Board of Directors
April 11, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting
April 07, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
April 03, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 12, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024
March 05, 2024
Abstract accepted for oral presentation on the evolving EGFR mutational landscape in NSCLC and MasterKey profile of BDTX-1535 addressing a broad spectrum of mutations
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
February 28, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones
January 04, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 13, 2023
Via
Benzinga
Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM
December 13, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 08, 2023
Via
Benzinga
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
November 07, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.